Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
"Telos Droplet Manufacture" does not appear to be the legal name of a standalone company; it most closely matches the Telos high-throughput droplet manufacturing system sold under the Dolomite Microfluidics brand. Dolomite Microfluidics developed microfluidic instruments, chips, and workflows for droplet generation, particle production, encapsulation, microreactions, and related life science and formulation applications. Its tools were used in areas such as drug delivery, lipid nanoparticle and microparticle formulation, single-cell and encapsulation workflows, and other research applications rather than as therapeutic products. Blacktrace Holdings, owner of the Dolomite brand, was acquired by Unchained Labs in July 2023. As of 2026, Unchained Labs has stated that the Dolomite product line has been discontinued, so the legacy business/brand is not active as an operating standalone company/product line in the market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Telos Droplet Manufacture.